title: L-Asparaginase-associated hyperlipidemia with hyperviscosity syndrome in a patient with T-cell lymphoblastic lymphoma.
authors.forename: B
authors.initials: B
authors.lastname: Meyer
authors.forename: W
authors.initials: W
authors.lastname: Hagen
authors.forename: W
authors.initials: W
authors.lastname: Scheithauer
authors.forename: L
authors.initials: L
authors.lastname: Ohler
authors.forename: G V
authors.initials: GV
authors.lastname: Kornek
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects*; D001809:Blood Viscosity; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D013577:Syndrome
chemical_list: D000970:Antineoplastic Agents; D001215:Asparaginase